This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Westan Pharmaceutical Technology Co., Ltd. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Yunfeng Cheng in Pharmaceutical Technology
Introduction
Yunfeng Cheng is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical technology, particularly through his innovative research and development of new compounds.
Latest Patents
One of his key patents is the "Heteroaromatic acetamide derivative, and preparation and use thereof." This invention provides a heteroaromatic acetamide derivative that can specifically bind to transient receptor potential ankyrin 1 (TRPA1). The patent outlines the preparation and use of this compound, which has been confirmed to inhibit or reduce the activity of TRPA1. This innovation holds potential for treating diseases mediated by TRPA1, showcasing its therapeutic applications.
Career Highlights
Yunfeng Cheng is associated with Hangzhou Westan Pharmaceutical Technology Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His work has led to the development of compounds that could significantly impact medical treatments.
Collaborations
Yunfeng Cheng collaborates with Yongzhou Hu, contributing to the advancement of their shared research goals. Their partnership enhances the potential for innovative discoveries in the pharmaceutical field.
Conclusion
Yunfeng Cheng's contributions to pharmaceutical technology, particularly through his patent on heteroaromatic acetamide derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile